Cajal Neuroscience’s $96 Million Series A Financing

Wilson Sonsini Goodrich & Rosati advised Cajal Neuroscience on the deal.Cajal Neuroscience Inc., a biotechnology company integrating human genetics, functional genomics, and advanced microscopy to discover…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here